NOVA1
Sign in to saveAlso known as Nova-1, NOVA alternative splicing regulator 1
RNA-binding protein Nova-1 is a protein that in humans is encoded by the NOVA1 gene.
Gene data
NOVA1- Name
- NOVA alternative splicing regulator 1
- Type
- protein-coding
- Position
- 26,443,090–26,598,033 (−)
- Aliases
- Nova-1
- Ensembl
- ENSG00000139910
- RefSeq RNA
- NM_001366390.2, NM_001366391.2, NM_001366392.2, NM_001366393.2, NM_001366394.2
- RefSeq protein
- NP_001353319.1, NP_001353320.1, NP_001353321.1, NP_001353322.1, NP_001353323.1
This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008].
Gene Ontology
Biological process
Molecular function
Cellular component
via MyGene.info
Wikidata facts
- Image
- Protein NOVA1 PDB 1dt4.png
Show 5 more facts
- HomoloGene ID
- 21296
- exact match
- identifiers.org/ncbigene/4857
- genomic end
- 27066960
- genomic start
- 26912299
- cytogenetic location
- 14q12
Sources (4)
via Wikidata · CC0
~1 min read
Article
2 sectionsContents
- References
- Further reading
RNA-binding protein Nova-1 is a protein that in humans is encoded by the NOVA1 gene.
This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described. Both Neanderthals and Denisovans had one version and nearly all modern humans had another suggesting positive selection. Insertion of Neanderthal gene variant of the neuro-oncological ventral antigen 1 (NOVA1) gene into human cortical organoids might promote slower development and higher surface complexity in the brain models, but this may be an artefact of a CRISPR side effect, as it could not be replicated in a subsequent study.